Biocompatible Polyurethane-Based Hydrogel
- 1 July 1994
- journal article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 9 (1) , 71-96
- https://doi.org/10.1177/088532829400900104
Abstract
A polyurethane polymer developed at W. R. Grace has been evaluated for a variety of biomedical applications. The primary property of the polymer exploited for these applications is its ability to prevent protein adsorption when coated on a surface. The prepolymer consists of a trifunctional poly(ethyleneoxide-propylene oxide) triol end capped with isophorone diisocyanate. The prepolymer is reactive with water and can be converted to a hydrogel, a thin coating, or a soluble conjugate with another compound. Each category lends itself to separate biomedical applications which are described in detail. The non-toxic nature of the polymer was demonstrated in a number of systems and suggests its utility in biomedical applications.Keywords
This publication has 16 references indexed in Scilit:
- A simple method for determining water‐induced gelling times of isocyanate prepolymersJournal of Applied Polymer Science, 1993
- Functional peptide-polyurethane conjugates with extended circulatory half-livesBioconjugate Chemistry, 1993
- Development of Gene Therapy for Immunodeficiency: Adenosine Deaminase DeficiencyPediatric Research, 1993
- A new hydrophilic polymer for biomaterial coatings with low protein adsorptionJournal of Biomaterials Science, Polymer Edition, 1992
- Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.Journal of Clinical Investigation, 1988
- Studies of the ocular compatibility of hydrogels. A review of the clinical manifestations of spoliationBiomaterials, 1987
- Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine DeaminaseNew England Journal of Medicine, 1987
- A Synthetic Peptide from Fibronectin Inhibits Experimental Metastasis of Murine Melanoma CellsScience, 1986
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- Deferoxamine in the Treatment of Acute Iron PoisoningClinical Pediatrics, 1966